![]() |
Neuraltus NP001 Phase 2 Trial: Targeting
Neuraltus NP001 Phase 2 Trial: Targeting Neuroinflammation to Slow ALS Progression
ALS Trials | ALS Clinical Research | Neuraltus NP 1 Phase 2 Trial: Targeting Neuroinflammation to Slow ALS Progression | Educational Webinars | For People with ALS & Caregivers | Northeast Amyotrophic Lateral Sclerosis (ALS) Consortium |
All times are GMT -5. The time now is 12:36 PM. |
Powered by vBulletin Copyright ©2000 - 2025, Jelsoft Enterprises Ltd.
vBulletin Optimisation provided by
vB Optimise (Lite) -
vBulletin Mods & Addons Copyright © 2025 DragonByte Technologies Ltd.